Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. A. Stockley (Birmingham, United Kingdom). Genetics and functional impairment in COPD. Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases

Member's Comments

No comment yet.

Related content which might interest you: Cognitive function in COPD Source: Eur Respir J 2010; 35: 913-922 Year: 2010 Montreal cognitive assessment in COPD Source: International Congress 2014 – Latest insights in chronic care Year: 2014 Cognitive impairment and clinical characteristics in patients with COPD Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases Year: 2016 Prevalence and determinants of cognitive impairment in COPD patients enrolled for Pulmonary Rehabilitation Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Sleep and cognitive impairment in COPD exacerbated and stable patients Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease Year: 2020 Pulmonary rehabilitation and cognitive impairment in COPD patients. Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 Genetic influences on lung function decline in AATD Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 Screening for cognitive impairment in patients with COPD Source: International Congress 2014 – Best abstracts in chronic care Year: 2014 The [bdquo]frequent exacerbator“ phenotype: Endothelial dysfunction and functional status Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Characterization of balance impairments in individuals with COPD Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011 Relationship between endothelial dysfunction and GOLD stage in patients with COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Premature aging and skeletal muscle dysfunction in COPD patients: Development of a cell culture model Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Associations between lung diffusion impairment, ventilatory inefficiency and exercise intolerance in mild to very severe COPD Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease Year: 2016 Assessment of endothelial dysfunction in COPD patients with different types of microcirculation disorders Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Presence of brain pathology in deceased subjects with and without COPD Source: International Congress 2014 – Latest insights in chronic care Year: 2014 Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort Source: Eur Respir J 2006; 28: Suppl. 50, 160s Year: 2006 Cognitive dysfunction in COPD and asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 55s Year: 2003 Functional ability in patients with COPD Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1 Year: 2020 Asthma control, severity and lung function impairment through network analysis in children Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia Year: 2015